4893 items matching your search terms.

Capecitabine ± bevacizumab in the adjuvant treatment of colorectal cancer: first and final toxicity results from the international phase III Quasar 2 trial

Midgley, RS Love, S Potter, V Segelov, E Ferry, DR Weaver, A Scudder, C Grumett, S Julier, P Kerr, DJ

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

Mihaylova, B Emberson, J Blackwell, L Keech, A Simes, J Barnes, EH Voysey, M Gray, A Collins, R Baigent, C on behalf of the Cholesterol Treatment Trialists' (CTT) Collaborators,

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials

Mihaylova, B. Emberson, J. Blackwell, L. Keech, A. Simes, J. Barnes, E. H. Voysey, M. Gray, A. Collins, R. Baigent, C. De Lemos, J. Braunwald, E. Blazing, M. Murphy, S. Downs, J. R. Gotto, A. Clearfield, M. Holdaas, H. Gordon, D. Davis, B. Koren, M. Dahlof, B. Poulter, N. Sever, P. Knopp, R. H. Fellstrom, B. Holdaas, H. Jardine, A. Schmieder, R. Zannad, F. Goldbourt, U. Kaplinsky, E. Colhoun, H. M. Betteridge, D. J. Durrington, P. N. Hitman, G. A. Fuller, J. Neil, A. Wanner, C. Krane, V. Sacks, F. Moye, L. Pfeffer, M. Hawkins, C. M. Braunwald, E. Kjekshus, J. Wedel, H. Wikstrand, J. Barter, P. Keech, A. Tavazzi, L. Maggioni, A. Marchioli, R. Tognoni, G. Franzosi, M. G. Maggioni, A. Bloomfield, H. Robins, S. Collins, R. Armitage, J. Keech, A. Parish, S. Peto, R. Sleight, P. Pedersen, T. R. Ridker, P. M. Holman, R. Meade, T. Simes, J. Keech, A. MacMahon, S. Marschner, I. Tonkin, A. Shaw, J. Serruys, P. W. Nakamura, H. Knatterud, G. Furberg, C. Byington, R. MacFarlane, P. Cobbe, S. Ford, I. Murphy, M. Blauw, G. J. Packard, C. Shepherd, J. Kjekshus, J. Pedersen, T. Wilhelmsen, L. Braunwald, E. Cannon, C. Murphy, S. Collins, R. Armitage, J. Bowman, L. Parish, S. Peto, R. Sleight, P. Landray, M. Collins, R. La Rosa, J. Rossouw, J. Probstfi Eld, J. Shepherd, J. Cobbe, S. MacFarlane, P. Ford, I. Flather, M. Kastelein, J. Newman, C. Shear, C. Tobert, J. Varigos, J. White, H. Yusuf, S. Mellies, M. McGovern, M. Barclay, J. Belder, R. Mitchel, M. Y. Musliner, T. Ansquer, J. C. Llewellyn, B. M. Pharma, N. Bortolini, M. Brandrup-Wognsen, G. Bryzinski, B. Olsson, G. Pears, J. DeMicco, D. Barnes, E. H. Baxter, A. Bhala, N. Blackwell, L. Buck, G. Collins, R. Emberson, J. Herrington, W. G. Holland, L. E. Kearney, P. M. Keech, A. Kirby, A. Lewis, D. A. Marschner, I. Pollicino, C. Reith, C. Simes, J. Sourjina, T.
THE LANCET, 2012     DOI:10.1016/S0140-6736(12)60367-5

Authors' reply

Mihaylova, B. Emberson, J. Keech, A. Collins, R. Baigent, C.
THE LANCET, 2012     DOI:10.1016/S0140-6736(12)62027-3

Statins for people at low risk of cardiovascular disease reply [letter]

Mihaylova, B Emberson, J Keech, A Collins, R Baigent, C Cholesterol Treatment Trialists' (CTT) Collaborators
LANCET, 2012     DOI:10.1016/S0140-6736(12)62027-3

A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: the OUTBACK trial

Mileshkin, LR Narayan, K Moore, KN Rischin, D Trimble, EL Stockler, MR King, M Kolodziej, I Martyn, J Friedlander, M Quinn, M Shrivastava, SK Small, W Thomas, G Craighead, PS Gebski, V Gynecologic Cancer Intergroup,

The IMPACT trial: Individualised Molecular Pancreatic Cancer Therapy. A randomised, open label, phase II trial assessing standard first line treatment with gemcitabine or personalised treatment based on tumour molecular signature in patients with recurrent or metastatic pancreatic cancer to evaluate feasibility and impact on progression free survival

Nagrial, A Biankin, A Chantrill, L Johns, A Chin, V Gebski, V Sjoquist, K Lee, C Yip, S Miller, D Sebastian, L Pavlakis, N Mukhedkar, S Asghari, R Simes, J

Sunlight and vitamin D affect DNA damage, cell division and cell death in human lymphocytes: a cross-sectional study in South Australia

Nair-Shalliker, V Fenech, M Forder, PM Clements, MS Armstrong, BK
MUTAGENESIS, 2012     DOI:10.1093/mutage/ges026

Early-stage squamous cell carcinoma of the lip: the Australian experience and the benefits of radiotherapy in improving outcome in high-risk patients after resection

Najim, M Cross, S Gebski, V Palme, CE Morgan, GJ Veness, MJ
HEAD AND NECK, 2012     DOI:10.1002/hed.23148

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

Neoptolemos, JP Moore, MJ Cox, TF Valle, JW Palmer, DH McDonald, AC Carter, R Tebbutt, NC Dervenis, C Smith, D Glimelius, B Charnley, RM Lacaine, F Scarfe, AG Middleton, MR Anthoney, A Ghaneh, P Halloran, CM Lerch, MM Oláh, A Rawcliffe, CL Verbeke, CS Campbell, F Büchler, MW European Study Group for Pancreatic Cancer,

Lp(a) concentration shows modest predictive power for coronary heart disease events: results from the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) trial

Nestel, P Sullivan, DR Fournier, M Tonkin, AM Blankenberg, S Colquhoun, DM Simes, RJ

Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer

Ng, M Leong, T Chander, S Chu, J Kneebone, A Carroll, S Wiltshire, K Ngan, S Kachnic, L

The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention

Ng, MK Yong, AS Ho, M Shah, MG Chawantanpipat, C O'Connell, R Keech, A Kritharides, L Fearon, WF

The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention

Ng, M. K. C. Yong, A. S. C. Ho, M. Shah, M. G. Chawantanpipat, C. O'Connell, R. Keech, A. Kritharides, L. Fearon, W. F.
CIRCULATION: CARDIOVASCULAR INTERVENTIONS, 2012     DOI:10.1161/CIRCINTERVENTIONS.112.969048

Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04

Ngan, SY Burmeister, B Fisher, RJ Solomon, M Goldstein, D Joseph, D Ackland, SP Schache, D McClure, B McLachlan, SA McKendrick, J Leong, T Hartopeanu, C Zalcberg, J Mackay, J
JOURNAL OF CLINICAL ONCOLOGY, 2012     DOI:10.1200/JCO.2012.42.9597